ECULIZUMAB , ECULIZUMAB
APHP211039
Phase 3 small_molecule active
Quick answer
ECULIZUMAB , ECULIZUMAB for Adult patients with aHUS associated with HE and severe kidney involvement (needing dialysis or serum creatinine ≥ 354μM) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients with aHUS associated with HE and severe kidney involvement (needing dialysis or serum creatinine ≥ 354μM)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active